Iron overload triggers redox-sensitive signals in human IMR-32 neuroblastoma cells

NeuroToxicology

Volumn 32, Issue 1, 2011, Pages 75-82

  Salvador, Gabriela A ^a   Oteiza, Patricia I ^b  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AP 1; Iron; Neurotoxicity; NF B; Oxidative stress

Indexed keywords

CASPASE 3; FERRIC AMMONIUM CITRATE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; ARTICLE; CELL LINE; CELL STRAIN IMR 32; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IRON OVERLOAD; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION;

CELL LINE, TUMOR; CELL SURVIVAL; FERRIC COMPOUNDS; HUMANS; IRON OVERLOAD; NEUROBLASTOMA; OXIDATION-REDUCTION; QUATERNARY AMMONIUM COMPOUNDS; SIGNAL TRANSDUCTION;

EID: 78951471098     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2010.11.006     Document Type: Article

References (48)

1. Ahsan M.K., Lekli I., Ray D., Yodoi J., Das D.K. Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart. Antioxid Redox Signal 2009, 11:2741-2758.
2. Aimo L., Oteiza P.I. Zinc deficiency increases the susceptibility of human neuroblastoma cells to lead-induced activator protein-1 activation. Toxicol Sci 2006, 91:184-191.
3. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat Med 2004, 10(Suppl.):S18-S25.
4. Barnham K.J., Bush A.I. Metals in Alzheimer's and Parkinson's diseases. Curr Opin Chem Biol 2008, 12:222-228.
5. Bartzokis G., Tishler T.A., Lu P.H., Villablanca P., Altshuler L.L., Carter M., et al. Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 2007, 28:414-423.
6. Berg D., Gerlach M., Youdim M.B., Double K.L., Zecca L., Riederer P., et al. Brain iron pathways and their relevance to Parkinson's disease. J Neurochem 2001, 79:225-236.
7. Berg D., Youdim M.B. Role of iron in neurodegenerative disorders. Top Magn Reson Imaging 2006, 17:5-17.
8. Bishop G.M., Dang T.N., Dringen R., Robinson S.R. Accumulation of non-transferrin-bound iron by neurons, astrocytes, and microglia. Neurotox Res 2010.
9. Borsello T., Forloni G. JNK signalling: a possible target to prevent neurodegeneration. Curr Pharm Des 2007, 13:1875-1886.
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
11. Brown L., Benchimol S. The involvement of MAPK signaling pathways in determining the cellular response to p53 activation: cell cycle arrest or apoptosis. J Biol Chem 2006, 281:3832-3840.
12. Connor J.R., Snyder B.S., Arosio P., Loeffler D.A., LeWitt P. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J Neurochem 1995, 65:717-724.
13. Crichton R.R., Charloteaux-Wauters M. Iron transport and storage. Eur J Biochem 1987, 164:485-506.
14. Crompton D.E., Chinnery P.F., Fey C., Curtis A.R., Morris C.M., Kierstan J., et al. Neuroferritinopathy: a window on the role of iron in neurodegeneration. Blood Cells Mol Dis 2002, 29:522-531.
15. Davila D., Torres-Aleman I. Neuronal death by oxidative stress involves activation of FOXO3 through a two-arm pathway that activates stress kinases and attenuates insulin-like growth factor I signaling. Mol Biol Cell 2008, 19:2014-2025.
16. Dhandapani K.M., Wade F.M., Wakade C., Mahesh V.B., Brann D.W. Neuroprotection by stem cell factor in rat cortical neurons involves AKT and NFkappaB. J Neurochem 2005, 95:9-19.
17. Fan Y., Chen H., Qiao B., Luo L., Ma H., Li H., et al. Opposing effects of ERK and p38 MAP kinases on HeLa cell apoptosis induced by dipyrithione. Mol Cells 2007, 23:30-38.
18. Halliwell B. The wanderings of a free radical. Free Radic Biol Med 2009, 46:531-542.
19. Ikeda F., Matsubara T., Tsurukai T., Hata K., Nishimura R., Yoneda T. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts. J Bone Miner Res 2008, 23:907-914.
20. Jiang D., Li X., Williams R., Patel S., Men L., Wang Y., et al. Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease. Biochemistry 2009, 48:7939-7947.
21. Kaltschmidt B., Heinrich M., Kaltschmidt C. Stimulus-dependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells. Neuromolecular Med 2002, 2:299-309.
22. Ke Y., Qian Z.M. Brain iron metabolism: neurobiology and neurochemistry. Prog Neurobiol 2007, 83:149-173.
23. Kell D.B. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics 2009, 2:2.
24. Kim J., Wong P.K. Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling. Stem Cells 2009, 27:1987-1998.
25. Kuperstein F., Yavin E. ERK activation and nuclear translocation in amyloid-beta peptide- and iron-stressed neuronal cell cultures. Eur J Neurosci 2002, 16:44-54.
26. Kuperstein F., Yavin E. Pro-apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity. J Neurochem 2003, 86:114-125.
27. Kwak E.L., Larochelle D.A., Beaumont C., Torti S.V., Torti F.M. Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem 1995, 270:15285-15293.
28. Mackenzie G.G., Oteiza P.I. Zinc and the cytoskeleton in the neuronal modulation of transcription factor NFAT. J Cell Physiol 2007, 210:246-256.
29. Mackenzie G.G., Zago M.P., Aimo L., Oteiza P.I. Zinc deficiency in neuronal biology. IUBMB Life 2007, 59:299-307.
30. Mackenzie G.G., Zago M.P., Erlejman A.G., Aimo L., Keen C.L., Oteiza P.I. Alpha-lipoic acid and N-acetyl cysteine prevent zinc deficiency-induced activation of NF-kappaB and AP-1 transcription factors in human neuroblastoma IMR-32 cells. Free Radic Res 2006, 40:75-84.
31. Mackenzie G.G., Zago M.P., Keen C.L., Oteiza P.I. Low intracellular zinc impairs the translocation of activated NF-kappa B to the nuclei in human neuroblastoma IMR-32 cells. J Biol Chem 2002, 277:34610-34617.
32. Mattson M.P. Apoptotic and anti-apoptotic synaptic signaling mechanisms. Brain Pathol 2000, 10:300-312.
33. Mattson M.P., Keller J.N., Begley J.G. Evidence for synaptic apoptosis. Exp Neurol 1998, 153:35-48.
34. Meffert M.K., Chang J.M., Wiltgen B.J., Fanselow M.S., Baltimore D. NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci 2003, 6:1072-1078.
35. Morse D., Pischke S.E., Zhou Z., Davis R.J., Flavell R.A., Loop T., et al. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 2003, 278:36993-36998.
36. Mossman B.T., Lounsbury K.M., Reddy S.P. Oxidants and signaling by mitogen-activated protein kinases in lung epithelium. Am J Respir Cell Mol Biol 2006, 34:666-669.
37. Ogunwobi O.O., Beales I.L. The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt. Int J Colorectal Dis 2007, 22:401-409.
38. Ong W.Y., Farooqui A.A. Iron, neuroinflammation, and Alzheimer's disease. J Alzheimers Dis 2005, 8:183-200.
39. Ortiz E., Pasquini J.M., Thompson K., Felt B., Butkus G., Beard J., et al. Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res 2004, 77:681-689.
40. Quintana C., Bellefqih S., Laval J.Y., Guerquin-Kern J.L., Wu T.D., Avila J., et al. Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J Struct Biol 2006, 153:42-54.
41. Quintana C., Gutierrez L. Could a dysfunction of ferritin be a determinant factor in the aetiology of some neurodegenerative diseases?. Biochim Biophys Acta 2010.
42. Rui T., Kvietys P.R. NFkappaB and AP-1 differentially contribute to the induction of Mn-SOD and eNOS during the development of oxidant tolerance. FASEB J 2005, 19:1908-1910.
43. Saito A., Maier C.M., Narasimhan P., Nishi T., Song Y.S., Yu F., et al. Oxidative stress and neuronal death/survival signaling in cerebral ischemia. Mol Neurobiol 2005, 31:105-116.
44. Salvador G.A. Iron in neuronal function and dysfunction. Biofactors 2010, 36:103-110.
45. Su B., Wang X., Nunomura A., Moreira P.I., Lee H.G., Perry G., et al. Oxidative stress signaling in Alzheimer's disease. Curr Alzheimer Res 2008, 5:525-532.
46. Todorich B., Pasquini J.M., Garcia C.I., Paez P.M., Connor J.R. Oligodendrocytes and myelination: the role of iron. Glia 2009, 57:467-478.
47. Uranga R.M., Giusto N.M., Salvador G.A. Iron-induced oxidative injury differentially regulates PI3K/Akt/GSK3beta pathway in synaptic endings from adult and aged rats. Toxicol Sci 2009, 111:331-344.
48. Voloboueva L.A., Killilea D.W., Atamna H., Ames B.N. N-tert-butyl hydroxylamine, a mitochondrial antioxidant, protects human retinal pigment epithelial cells from iron overload: relevance to macular degeneration. FASEB J 2007, 21:4077-4086.